PLoS ONE (Jan 2014)

Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

  • Pierre Soubeyran,
  • Carine Bellera,
  • Jean Goyard,
  • Damien Heitz,
  • Hervé Curé,
  • Hubert Rousselot,
  • Gilles Albrand,
  • Véronique Servent,
  • Olivier Saint Jean,
  • Isabelle van Praagh,
  • Jean-Emmanuel Kurtz,
  • Stéphane Périn,
  • Jean-Luc Verhaeghe,
  • Catherine Terret,
  • Christophe Desauw,
  • Véronique Girre,
  • Cécile Mertens,
  • Simone Mathoulin-Pélissier,
  • Muriel Rainfray

DOI
https://doi.org/10.1371/journal.pone.0115060
Journal volume & issue
Vol. 9, no. 12
p. e115060

Abstract

Read online

Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify the best screening tool to identify older cancer patients requiring geriatric assessment by comparing the performance of two short assessment tools the G8 and the Vulnerable Elders Survey (VES-13).The diagnostic accuracy of the G8 and the (VES-13) were evaluated in a prospective cohort study of 1674 cancer patients accrued before treatment in 23 health care facilities. 1435 were eligible and evaluable. Outcome measures were multidimensional geriatric assessment (MGA), sensitivity (primary), specificity, negative and positive predictive values and likelihood ratios of the G8 and VES-13, and predictive factors of 1-year survival rate.Patient median age was 78.2 years (70-98) with a majority of females (69.8%), various types of cancer including 53.9% breast, and 75.8% Performance Status 0-1. Impaired MGA, G8, and VES-13 were 80.2%, 68.4%, and 60.2%, respectively. Mean time to complete G8 or VES-13 was about five minutes. Reproducibility of the two questionnaires was good. G8 appeared more sensitive (76.5% versus 68.7%, P = 0.0046) whereas VES-13 was more specific (74.3% versus 64.4%, P<0.0001). Abnormal G8 score (HR = 2.72), advanced stage (HR = 3.30), male sex (HR = 2.69) and poor Performance Status (HR = 3.28) were independent prognostic factors of 1-year survival.With good sensitivity and independent prognostic value on 1-year survival, the G8 questionnaire is currently one of the best screening tools available to identify older cancer patients requiring geriatric assessment, and we believe it should be implemented broadly in daily practice. Continuous research efforts should be pursued to refine the selection process of older cancer patients before potentially life-threatening therapy.